0.00
price down icon100.00%   -63.48
after-market After Hours: 63.50 63.50 +
loading
Catalent Inc stock is traded at $0.00, with a volume of 0. It is down -100.00% in the last 24 hours and down -100.00% over the past month.
See More
Previous Close:
$63.48
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$11.52B
Revenue:
$4.42B
Net Income/Loss:
$-413.00M
P/E Ratio:
0.00
EPS:
-1.3
Net Cash Flow:
$99.00M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
Value
$0.00
$0.00
1-Week Range:
Value
$0.00
$63.50
52-Week Range:
Value
$0.00
$63.50

Catalent Inc Stock (CTLT) Company Profile

Name
Name
Catalent Inc
Name
Phone
(732) 537-6200
Name
Address
14 SCHOOLHOUSE ROAD, SOMERSET, NJ
Name
Employee
0
Name
Twitter
@catalentpharma
Name
Next Earnings Date
2024-11-13
Name
Latest SEC Filings
Name
CTLT's Discussions on Twitter

Compare CTLT with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Drug Manufacturers - Specialty & Generic icon
CTLT
Catalent Inc
0.00 11.52B 4.42B -413.00M 99.00M -2.27
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
164.28 74.12B 9.15B 2.43B 2.31B 5.32
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.72 43.95B 14.26B 1.55B 0 0.3383
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
13.17 41.75B 30.27B 1.93B 3.45B 0.6044
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
22.21 25.17B 16.77B -959.00M 1.37B -0.85
Drug Manufacturers - Specialty & Generic icon
VTRS
Viatris Inc
12.49 14.91B 15.05B -883.30M 1.89B -0.74

Catalent Inc Stock (CTLT) Upgrades & Downgrades

Date Action Analyst Rating Change
Nov-16-23 Upgrade Robert W. Baird Neutral → Outperform
Sep-05-23 Upgrade Argus Hold → Buy
Jul-20-23 Initiated Wells Fargo Equal Weight
Jul-05-23 Resumed JP Morgan Neutral
Jun-14-23 Downgrade Jefferies Buy → Hold
May-22-23 Downgrade JP Morgan Overweight → Neutral
May-15-23 Downgrade Deutsche Bank Buy → Hold
May-08-23 Downgrade BofA Securities Neutral → Underperform
Apr-17-23 Downgrade Robert W. Baird Outperform → Neutral
Apr-14-23 Downgrade William Blair Outperform → Mkt Perform
Apr-10-23 Upgrade Deutsche Bank Hold → Buy
Apr-03-23 Downgrade Barclays Overweight → Equal Weight
Dec-19-22 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Nov-07-22 Downgrade Argus Buy → Hold
Nov-02-22 Downgrade BofA Securities Buy → Neutral
Dec-16-21 Initiated Barclays Overweight
Dec-10-20 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Jun-25-20 Initiated Argus Buy
Apr-21-20 Initiated RBC Capital Mkts Outperform
Mar-02-20 Initiated Deutsche Bank Hold
Oct-17-19 Resumed Stephens Overweight
Aug-28-19 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Jun-21-19 Upgrade Jefferies Hold → Buy
Apr-16-19 Upgrade UBS Neutral → Buy
Nov-07-18 Upgrade First Analysis Sec Neutral → Outperform
Oct-09-18 Initiated UBS Neutral
Mar-28-18 Upgrade KeyBanc Capital Mkts Sector Weight → Overweight
Mar-21-18 Upgrade Raymond James Mkt Perform → Outperform
Feb-06-18 Downgrade Stephens Overweight → Equal-Weight
Sep-21-17 Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-13-17 Initiated Needham Hold
Sep-08-17 Downgrade KeyBanc Capital Mkts Overweight → Sector Weight
Dec-01-16 Initiated Goldman Neutral
Oct-20-16 Initiated KeyBanc Capital Mkts Overweight
Jun-21-16 Upgrade Wells Fargo Market Perform → Outperform
Jun-20-16 Upgrade BofA/Merrill Neutral → Buy
View All

Catalent Inc Stock (CTLT) Latest News

pulisher
Dec 20, 2024

Novo Holdings completes purchase of Catalent - MSN

Dec 20, 2024
pulisher
Dec 20, 2024

Novo Nordisk Set to Close Catalent Deal Without FTC Challenge - MSN

Dec 20, 2024
pulisher
Dec 20, 2024

Novo Holdings completes $16.5 billion takeover of Catalent - MSN

Dec 20, 2024
pulisher
Dec 19, 2024

Novo Holdings says its acquisition of Catalent is complete. - The Herald-Times

Dec 19, 2024
pulisher
Dec 19, 2024

Catalent, Inc Announces Board Changes - Marketscreener.com

Dec 19, 2024
pulisher
Dec 19, 2024

Regulatory conditions on Novo Holdings' $16.5 billion Catalent deal fulfilled, companies say - MSN

Dec 19, 2024
pulisher
Dec 19, 2024

Novo Holdings closes $16.5 billion buyout of contract manufacturer Catalent - MSN

Dec 19, 2024
pulisher
Dec 19, 2024

Novo Holdings completes Catalent acquisition for $16.5bn - Yahoo Finance

Dec 19, 2024
pulisher
Dec 18, 2024

Lennox To Join S&P 500 Index, Replacing Catalent - Yahoo! Voices

Dec 18, 2024
pulisher
Dec 18, 2024

This industrials company is joining the S&P 500 soon - MSN

Dec 18, 2024
pulisher
Dec 18, 2024

Novo Holdings completes $16.5B acquisition of Catalent - Inside INdiana Business

Dec 18, 2024
pulisher
Dec 18, 2024

Novo Completes $16.5 Billion Acquisition of Catalent - Yahoo Finance

Dec 18, 2024
pulisher
Dec 18, 2024

Novo Holdings Completes Acquisition of Catalent - citybiz

Dec 18, 2024
pulisher
Dec 18, 2024

Novo Holdings Strengthens Pharma Standing With Catalent Acquisition - Finimize

Dec 18, 2024
pulisher
Dec 18, 2024

Catalent Acquired by Novo Holdings in $16.5 Billion Deal - TipRanks

Dec 18, 2024
pulisher
Dec 18, 2024

Novo Holdings Finalizes $16.5 Billion Acquisition of CatalentNews and Statistics - IndexBox, Inc.

Dec 18, 2024
pulisher
Dec 18, 2024

Catalent : Novo Holdings Completes Acquisition of Catalent Form 8 K - Marketscreener.com

Dec 18, 2024
pulisher
Dec 18, 2024

Catalent acquired by Novo Holdings for $16.5 billion - Investing.com

Dec 18, 2024
pulisher
Dec 18, 2024

Novo Holdings has completed the acquisition of Catalent - Marketscreener.com

Dec 18, 2024
pulisher
Dec 18, 2024

The acquisition of Catalent by Novo Holdings, and the - GlobeNewswire

Dec 18, 2024
pulisher
Dec 18, 2024

The acquisition of Catalent by Novo Holdings, and the related acquisition by Novo Nordisk of three manufacturing sites from Novo Holdings, is completed - Yahoo Finance

Dec 18, 2024
pulisher
Dec 17, 2024

Novo Nordisk Invests $1.2 Billion in New Denmark Factory, Fresh Off Catalent Deal - geneonline

Dec 17, 2024
pulisher
Dec 16, 2024

Catalent wins EU approval for planned $16.5B sale to Novo Holdings - MSN

Dec 16, 2024
pulisher
Dec 16, 2024

Novo Nordisk’s New Deal May End Wegovy Shortages. It Could Reshape Pharma Industry Along the Way. - Barron's

Dec 16, 2024
pulisher
Dec 16, 2024

Danish pharma giant cleared to buy Catalent - Indiana Public Media

Dec 16, 2024
pulisher
Dec 16, 2024

House Panel Accuses Financial Firms of Collusion Over ESG Goals - PYMNTS.com

Dec 16, 2024
pulisher
Dec 16, 2024

Novo Holdings Completes Regulatory Hurdles For Catalent Acquisition - Contract Pharma

Dec 16, 2024
pulisher
Dec 16, 2024

Novo Holdings’ $16.5B deal for Catalent clears last regulatory hurdle - MM+M Online

Dec 16, 2024
pulisher
Dec 16, 2024

Novo Nordisk stock rises following regulatory clearance of Catalent deal - Investing.com

Dec 16, 2024
pulisher
Dec 16, 2024

Novo Nordisk stock rises following regulatory clearance of Catalent deal By Investing.com - Investing.com Australia

Dec 16, 2024
pulisher
Dec 16, 2024

Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction - Marketscreener.com

Dec 16, 2024
pulisher
Dec 16, 2024

Novo Holdings’ purchase of Catalent set to close after regulators’ green light - BioPharma Dive

Dec 16, 2024
pulisher
Dec 16, 2024

Catalent (NYSE:CTLT) Sets New 12-Month HighTime to Buy? - MarketBeat

Dec 16, 2024
pulisher
Dec 16, 2024

Novo Catalent deal clears regulatory hurdles - BioProcess Insider

Dec 16, 2024
pulisher
Dec 16, 2024

Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent - Yahoo Finance

Dec 16, 2024
pulisher
Dec 16, 2024

Denmark's Novo Nordisk has received FTC approval to acquire three Catalent plants for $11.7 billion - AK&M News

Dec 16, 2024
pulisher
Dec 16, 2024

Catalent, Inc. (CTLT) and Novo Holdings A/S Announce Fulfillment of Regulatory Conditions - GuruFocus.com

Dec 16, 2024
pulisher
Dec 16, 2024

Novo Holdings Gets FTC’s Go-Ahead for Contentious $16.5B Catalent Acquisition - BioSpace

Dec 16, 2024
pulisher
Dec 16, 2024

Catalent : and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction Form 8 K - Marketscreener.com

Dec 16, 2024
pulisher
Dec 16, 2024

Novo Holding's purchase of Catalent soon to be completed - Marketscreener.com

Dec 16, 2024
pulisher
Dec 15, 2024

Toronto Dominion Bank Lowers Holdings in Catalent, Inc. (NYSE:CTLT) - MarketBeat

Dec 15, 2024
pulisher
Dec 15, 2024

Catalent, Inc. (NYSE:CTLT) Shares Sold by Geode Capital Management LLC - MarketBeat

Dec 15, 2024
pulisher
Dec 15, 2024

Novo Holdings Seals The Deal On Catalent Acquisition - Finimize

Dec 15, 2024

Catalent Inc Stock (CTLT) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
drug_manufacturers_specialty_generic RDY
$15.49
price up icon 0.78%
$136.99
price up icon 1.16%
$84.00
price up icon 0.66%
$12.49
price down icon 0.24%
$91.01
price up icon 1.93%
$11.86
price up icon 1.98%
Cap:     |  Volume (24h):